Sundaram Multi Pap Ltd

Sundaram Multi's historical performance has shown a decline in net sales and profitability, with net sales dropping from 156.37 Cr in March 2014 to 96.99 Cr in March 2020, and profit before tax turning negative at -2.70 Cr in March 2020. The company's financial position has tightened, reflected in decreasing total assets and liabilities.

Sundaram Multi's historical performance shows a decline in net sales from 156.37 Cr in Mar'14 to 96.99 Cr in Mar'20, with operating profit dropping significantly and profit before tax turning negative at -2.70 Cr in Mar'20. Overall, the company's financial health has deteriorated in recent years.

As of 07-Oct, Sundaram Multi Pap Ltd's stock price is Rs 1.85, down 2.63% and underperforming against the Sensex, which has gained 4.85% year-to-date. The stock is near its 52-week low and has seen significant declines over the past week, month, and year, indicating a bearish trend and declining investor confidence.

As of 25-Sep, Sundaram Multi Pap Ltd's stock price is at 1.97, showing a slight increase but trading below all key moving averages, indicating weak performance. The stock has significantly underperformed the Sensex over the past year and faces challenges with poor long-term fundamentals and a negative outlook.

Sundaram Multi Pap Ltd experienced notable trading activity today, reaching its upper circuit limit with a significant increase in investor participation. The stock recorded a high of 2.38 and a total traded volume of approximately 11.47 lakh shares, indicating a dynamic presence in the market.

Sundaram Multi Pap Ltd, a microcap in the miscellaneous sector, reached its upper circuit limit today, with significant trading activity and a notable increase in delivery volume. The stock outperformed its sector and the broader market, indicating strong investor interest and a dynamic trading environment.

Sundaram Multi has experienced significant fluctuations in financial performance, with net sales and operating profit declining from Mar'14 to Mar'20, culminating in a negative profit before tax and net profit in Mar'20. Overall, the company has shown considerable volatility and losses in recent years.

Sundaram Multi Pap's latest results are concerning, with a 4.15% decline in net sales and a significant 276% drop in net profit compared to the previous year, indicating ongoing operational challenges. Stakeholders should monitor the company's performance closely in the upcoming quarters.

Sundaram Multi Pap has reported a flat financial performance for the quarter ending June 2025, with a notable decline in profit before tax from other income. The company's stock has fluctuated, showing a significant year-over-year decline, indicating challenges that may require strategic reassessment for improved competitiveness.

Sundaram Multi's historical performance has shown a declining trend in net sales and profits, with net sales dropping from INR 156.37 crore in March 2014 to INR 96.99 crore in March 2020, and net profit turning negative at INR -2.70 crore in March 2020. Operating profit peaked in March 2019 but fell significantly by March 2020, reflecting overall volatility in financial metrics.

Sundaram Multi Pap's latest results are poor, with a significant decline in Profit Before Tax (PBT) and Profit After Tax (PAT), marking the lowest figures in five quarters, alongside a decrease in net sales. Overall, the company is facing a challenging operational environment.